OTCMKTS:CHEOF Cochlear (CHEOF) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free CHEOF Stock Alerts $209.00 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$209.00▼$209.0050-Day Range$208.50▼$230.4652-Week Range$145.73▼$230.46Volume110 shsAverage Volume166 shsMarket CapitalizationN/AP/E Ratio127.28Dividend Yield0.61%Price TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Cochlear alerts: Email Address Ad Insider FinancialThousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage" About Cochlear Stock (OTCMKTS:CHEOF)Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More CHEOF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHEOF Stock News HeadlinesApril 19, 2024 | americanbankingnews.comCochlear (OTCMKTS:CHEOF) Stock Price Down 0.5%July 26, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Cochlear Limited (OtherCHEOF)April 24, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…July 20, 2023 | msn.comChandy’s Cochlear Implant Scheme hits hurdles, parents seek government helpJuly 19, 2023 | benzinga.comSensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in EuropeJuly 18, 2023 | msn.com7-year-old girl hears for first time after Chhattisgarh govt sponsors operation, father wants her to become doctorJuly 18, 2023 | msn.comOommen Chandy: Humane leader who put patients first, say health expertsJuly 10, 2023 | markets.businessinsider.comMorgan Stanley Keeps Their Hold Rating on Cochlear Limited (CHEOF)April 24, 2024 | Insider Financial (Ad)Thousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.July 10, 2023 | benzinga.comSensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UKJuly 5, 2023 | benzinga.comSensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical StudyJune 25, 2023 | msn.comRajasthan: Govt announces ₹1 lakh airfare for travel for organ transplantJune 25, 2023 | thetimes.co.ukNHS may have missed thousands of deaf children in ‘huge national failure’June 22, 2023 | morningstar.comFTSE 100 Closes Down 0.75% After Rate Hike; Ocado Surges on Bid SpeculationJune 22, 2023 | afr.comLabor bows to pressure on multinational tax disclosureJune 19, 2023 | finance.yahoo.comSensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical StudyMay 22, 2023 | afr.com‘Next Cochlear’ stock surges after heart device breakthroughMay 4, 2023 | marketwatch.comCochlear Implants Market Share | Business till 2030May 3, 2023 | msn.comParents to inform SA cochlear implant reviewApril 20, 2023 | msn.comTownsville University Hospital staff stood down amid review of paediatric audiology unit outcomesApril 16, 2023 | afr.comAustralian business delegation heads to ChinaApril 11, 2023 | msn.comSurgeries of chronically ill children in Pune pending under RBSKApril 6, 2023 | marketwatch.comCochlear Implant (CI) Systems Market 2023-2030| Expert Analysis of Current Trend and Scope to Drive the MarketApril 6, 2023 | marketwatch.comSensorion Announces Candidate Selection for GJB2 Gene Therapy ProgramMarch 22, 2023 | uk.news.yahoo.comDad runs half marathon to help deaf babies like his sonMarch 22, 2023 | nasdaq.comCochlear, Demant contest UK regulator's Oticon deal concernsMarch 21, 2023 | markets.businessinsider.comDr. Jace Wolfe named Senior Vice President at Oberkotter Foundation - Hearing FirstSee More Headlines Receive CHEOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:CHEOF CUSIPN/A CIK1453930 Webwww.cochlear.com Phone(129) 428-6555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio127.28 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Diggory William Howitt BE (Hons) (Age 57)MBA, CEO, MD, President & Executive Director Comp: $3.1MMr. Stuart SayersChief Financial OfficerMr. Jan Janssen MSc Elec Eng (Age 59)Chief Technology Officer Comp: $1.32MMs. Karen O'DriscollChief Information OfficerMs. Kristina DevonVice President of Investor RelationsRob McGroryGroup General CounselMs. Jennifer StevensonVP of Corporate Communications & BrandMr. Dean PhizackleaSenior Vice President of Global Strategic MarketingMs. Jennifer HornerySenior Vice President of Global People & CultureMr. Greg Bodkin BE (Hons)MComm (UNSW), Senior Vice President of Global Supply ChainMore ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors CHEOF Stock Analysis - Frequently Asked Questions How have CHEOF shares performed in 2024? Cochlear's stock was trading at $198.50 at the beginning of the year. Since then, CHEOF shares have increased by 5.3% and is now trading at $209.00. View the best growth stocks for 2024 here. Is Cochlear a good dividend stock? Cochlear (OTCMKTS:CHEOF) pays an annual dividend of $1.27 per share and currently has a dividend yield of 2.07%. The dividend payout ratio is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable. How do I buy shares of Cochlear? Shares of CHEOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CHEOF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.